HR Execs on the Move

Immunic

www.imux.com

 
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. The company is developing three small molecule products: its lead development program, IMU-838, a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH and exhibits a host-based antiviral effect, is currently being developed as a treatment option for multiple sclerosis, ulcerative colitis, Crohn`s disease, and primary sclerosing cholangitis. IMU-935, a selective inverse agonist of the transcription factor RORγt, is targeted for development in psoriasis and Guillain-Barré syndrome. ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.imux.com
  • 1200 Avenue of the Americas Suite 200
    New York, NY USA 10036
  • Phone: 332.255.9811

Executives

Name Title Contact Details

Similar Companies

Locus Pharmaceuticals

Locus Pharmaceuticals, Inc. is a world leader in fragment-based, computational drug design. We have combined highly integrated chemistry, crystallography and biology capabilities to create a unique drug design and development platform for oral drug

Flexicare

Flexicare is a privately owned, leading manufacturer and supplier of medical devices with over 40 years of experience in the healthcare sector. With over 40 years of experience in the design, development and manufacture of medical devices, Flexicare ha...

Risas Dental and Braces

Affordable dental and orthodontics for the whole family by top doctors! Open Mon-Sat 9am-8pm. 24 locations in Arizona, Colorado, Nevada, and Texas

Janssen Pharmaceuticals

Janssen Pharmaceuticals is a Titusville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oncologie

Oncologie is a global oncology biotech company dedicated to biomarker-driven development of large & small molecules.